<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Archives des Monitoring - Actulligence</title>
	<atom:link href="https://www.actulligence.com/en/category/monitoring-en/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.actulligence.com/en/category/monitoring-en/</link>
	<description>Transformez l&#039;information en action</description>
	<lastBuildDate>Tue, 31 Mar 2026 15:01:17 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.actulligence.com/wp-content/uploads/2023/10/favicon_Actulligence-150x150.png</url>
	<title>Archives des Monitoring - Actulligence</title>
	<link>https://www.actulligence.com/en/category/monitoring-en/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>How to use the clinicaltrials.gov website for monitoring</title>
		<link>https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/</link>
					<comments>https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Tue, 12 Mar 2024 12:45:57 +0000</pubDate>
				<category><![CDATA[Competitive intelligence]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Non classé]]></category>
		<category><![CDATA[Pharma]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=7046</guid>

					<description><![CDATA[<p>When it comes to competitive intelligence in the pharmaceutical sector, one of the key areas to monitor is clinical trials conducted by competitors. One of the best-known and most visible websites in the world is the U.S. Food and Drug Administration’s www.clinicaltrials.gov NB: This article refers to the new version of the clinicaltrials.gov website, which [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/">How to use the clinicaltrials.gov website for monitoring</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2024/03/12/how-to-use-the-clinicaltrials-gov-website-for-monitoring/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Social listening: avoiding the pitfalls of a hasty analysis</title>
		<link>https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/</link>
					<comments>https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/#respond</comments>
		
		<dc:creator><![CDATA[Julien B]]></dc:creator>
		<pubDate>Tue, 08 Oct 2019 11:05:53 +0000</pubDate>
				<category><![CDATA[Actulligence @en]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Online reputation]]></category>
		<category><![CDATA[e-Reputation]]></category>
		<category><![CDATA[ereputation]]></category>
		<category><![CDATA[social listening platform]]></category>
		<category><![CDATA[social listening software]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/</guid>

					<description><![CDATA[<p>Many are the businesses wishing to speed up their digital transformation by implementing new services for their marketing and communications teams, or by integrating new technologies as data lakes or artificial intelligence. Social listening has been part of this trend through editors promoting innovative technologies able to provide insights as fast as we heat up [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/">Social listening: avoiding the pitfalls of a hasty analysis</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/10/08/social-listening-avoiding-the-pitfalls-of-a-hasty-analysis/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Pharma industry, drug life cycle and social listening</title>
		<link>https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/</link>
					<comments>https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Tue, 17 Sep 2019 16:10:24 +0000</pubDate>
				<category><![CDATA[Actulligence @en]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[Online reputation]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[pharmaceutique]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/2019/09/17/industrie-pharmaceutique-cycle-de-vie-du-medicament-et-social-media/</guid>

					<description><![CDATA[<p>At Actulligence, we are deeply convinced that business intelligence should not be a burden on any organization. It should rely on the organization’s existing processes to answer operational and business needs and be integrated depending on how the user operates. The usual cliché of business intelligence is the « intelligence cycle », as defined by Henri Martre [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/">Pharma industry, drug life cycle and social listening</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/09/17/pharma-industry-drug-life-cycle-and-social-listening/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>GDPR, customs barrier to access to information</title>
		<link>https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/</link>
					<comments>https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Wed, 03 Jul 2019 13:00:52 +0000</pubDate>
				<category><![CDATA[Competitive intelligence]]></category>
		<category><![CDATA[Economic warfare]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Indexation]]></category>
		<category><![CDATA[Information - Data management]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[gprd]]></category>
		<category><![CDATA[information retrieval]]></category>
		<category><![CDATA[regulatory]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=3729</guid>

					<description><![CDATA[<p>Basically, the GDPR is a law that aims to protect the internet user, and more particularly allows him to better manage his personal data, and generally any information that could be used by a website, whether the data is explicitly provided (contact form, newsletter subscription, survey, etc.) or implicitly provided (environment data such as operating [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/">GDPR, customs barrier to access to information</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2019/07/03/gdpr-customs-barrier-to-access-to-information/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Twitter and RSS feeds: make monitoring easy on Twitter</title>
		<link>https://www.actulligence.com/en/2012/04/26/twitter-and-rss-feeds-make-monitoring-easy-on-twitter/</link>
					<comments>https://www.actulligence.com/en/2012/04/26/twitter-and-rss-feeds-make-monitoring-easy-on-twitter/#respond</comments>
		
		<dc:creator><![CDATA[Frédéric Martinet]]></dc:creator>
		<pubDate>Thu, 26 Apr 2012 14:44:29 +0000</pubDate>
				<category><![CDATA[Blog - RSS - 2.0]]></category>
		<category><![CDATA[en]]></category>
		<category><![CDATA[Monitoring]]></category>
		<category><![CDATA[Monitoring tools]]></category>
		<category><![CDATA[atom]]></category>
		<category><![CDATA[competitive search]]></category>
		<category><![CDATA[monitoring]]></category>
		<category><![CDATA[rss]]></category>
		<category><![CDATA[search software]]></category>
		<category><![CDATA[strategic search]]></category>
		<guid isPermaLink="false">https://www.actulligence.com/?p=2185</guid>

					<description><![CDATA[<p>Some weeks ago Twitter changed its search results pages and removed the links pointing to the RSS feed for the search results. This was probably done in order to limit calls on its infrastructure by software not using its APIs which could therefore affect the proper working of its infrastructure. Anyway, these RSS URLs have not completely vanished [&#8230;]</p>
<p>L’article <a href="https://www.actulligence.com/en/2012/04/26/twitter-and-rss-feeds-make-monitoring-easy-on-twitter/">Twitter and RSS feeds: make monitoring easy on Twitter</a> est apparu en premier sur <a href="https://www.actulligence.com/en/home-2/">Actulligence</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.actulligence.com/en/2012/04/26/twitter-and-rss-feeds-make-monitoring-easy-on-twitter/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
